AstraZeneca rolls out online reading tool for U.S. docs; Journal ad revenue on the upswing; Sanofi unveils app for Kenyan moms;

> AstraZeneca ($AZN) launched a new online tool for U.S. doctors, DoctorsNotes, that's designed to help physicians annotate and organize their online reading. Report

> Advertising in medical journals grew by 8.7% for the first half of 2014, to $165 million, with a 3% increase in ad pages. Report

> Sanofi ($SNY) rolled out Mommy's App, a health tracker for infants, in Kenya in partnership with the Kenya Pediatric Association. Report

> The European Medicines Agency tapped Marie-Agnes Heine to lead its communication department; previously she was a communications officer with the World Health Organization. Report

> The medical communications firm Fishawack has opened a new U.S. office in San Francisco to handle West Coast clients; Fishawack expanded its East Coast team earlier this year. Report

And Finally... A bit less than half of U.S. physicians want the new iPhone with a larger, 5.5-inch screen. Report

Suggested Articles

Pfizer and Astellas are chasing a new nod for prostate cancer drug Xtandi, and thanks to the FDA, they might not have to wait that long.

As AZ and FibroGen have yet to submit the novel anemia drug to the U.S. regulators, national reimbursement talks are already underway in China.

Health and Human Services, hoping to resurrect a rule that would force drug prices into TV ads, appealed a judge's decision that blocked it.